NCT05709860Completed
An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy
Adaptation and Pilot Test of an Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy
Source: ClinicalTrials.gov · Last updated 30 May 2025
Brief summary (registry, in English)
This study is being conducted to investigate a strategy that may improve knowledge and uptake of pre-exposure prophylaxis for HIV prevention (PrEP) among cisgender women in primary care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 17 Jan 2023
- Start date
- 29 Nov 2023
- Primary completion date
- 29 Oct 2024
- Lead sponsor
- Northwestern University
- Diseases
- HIV
- NCT number
- NCT05709860
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 29 Nov 2023 to the primary completion date, 29 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- severe, uncorrectable visual, hearing or cognitive impairments that would preclude study consent or participation
Who the study is looking for
- female
- HIV negative
- have received 2 or more tests in the past 12 months for chlamydia, gonorrhea and/or syphilis
- and/or have received a positive diagnosis for at least one of those sexually transmitted infections in the past 6 months
- currently engaged in primary care
- not currently using PrEP
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.